Загрузка...
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients
Treatment of transplant-ineligible (TNE) newly diagnosed multiple myeloma (NDMM) requires a balance between disease control and maintaining quality of life (QoL). Patients value treatment-free remission periods in this incurable condition, as they are associated with better QoL. We set out to study...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034914/ https://ncbi.nlm.nih.gov/pubmed/32084254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229469 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|